https://www.selleckchem.com/products/vbit-4.html
Data from the Improving Outcomes and Antibiotic Stewardship for Patients with Bloodstream Infections Accelerate PhenoTest™ BC Kit (AXDX) Registry Study were analysed to determine the impact of rapid organism identification and antimicrobial susceptibility testing (AST) for Gram-positive bacteraemia. This multicentre, quasi-experimental study evaluated clinical and antimicrobial stewardship metrics following the implementation of AXDX. Data from hospitalized patients with bacteraemia were compared between groups, one that underwent testin
Beğen
Yorum Yap
Paylaş
